Peter McCartney

Dr. Peter McCartney is an Honorary Clinical Fellow at the School of Cardiovascular & Metabolic Health, University of Glasgow. His research focuses on coronary artery disease, myocardial infarction, and interventional cardiology, with particular expertise in coronary microvascular function and percutaneous coronary intervention (PCI) optimization. He has contributed to landmark trials like CorMicA and T-TIME, investigating stratified medical therapy and adjunctive therapies in cardiovascular conditions.

His work spans clinical trials, systematic reviews, and meta-analyses, addressing topics such as coronary perforation management, stent optimization, and microvascular injury assessment. McCartney collaborates widely, including with colleagues at the University of Glasgow and international institutions, to advance diagnostic and therapeutic strategies in cardiovascular medicine. No scientific awards are explicitly mentioned in the provided materials.

His publications emphasize patient outcomes, procedural improvements, and invasive coronary function testing. He has been involved in designing trials evaluating therapies like mineralocorticoid receptor antagonists and low-dose intracoronary alteplase. No specific grants or lab affiliations are detailed in the text.